Real-World data reveals Isavuconazole's effectiveness against deadly fungal infections
NCT ID NCT04550936
First seen Jan 11, 2026 · Last updated May 07, 2026 · Updated 18 times
Summary
This study reviewed medical charts of 307 adults in five European countries who were treated with isavuconazole for invasive aspergillosis or mucormycosis. Researchers tracked how well the drug worked, its safety, and how it was used in routine care. The goal was to understand real-world outcomes, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCORMYCOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino
Turin, Piedmont, 10126, Italy
-
CHU de Limoges
Limoges, 87042, France
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Comprehensive Cancer Center Ulm (CCCU)
Ulm, 89081, Germany
-
Fundació Clínic Per A La Recerca Biomèdica
Barcelona, 08036, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, 39011, Spain
-
Institut de Cancérologie
Strasbourg, 67033, France
-
King'S College Hospital Nhs Foundation Trust
London, SE5 9RS, United Kingdom
-
Klinikum rechts der Isar Technische Universität München
Munich, 81675, Germany
-
Paris University
Paris, 75015, France
-
University Hospital Miguel Servet
Zaragoza, 50009, Spain
-
University Hospital of Cologne
Cologne, 50937, Germany
-
Universitätsklinik Frankfurt
Frankfurt, 60590, Germany
-
Vall d'Hebron University Hospital
Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.